SE364284B - - Google Patents
Info
- Publication number
- SE364284B SE364284B SE388168A SE388168A SE364284B SE 364284 B SE364284 B SE 364284B SE 388168 A SE388168 A SE 388168A SE 388168 A SE388168 A SE 388168A SE 364284 B SE364284 B SE 364284B
- Authority
- SE
- Sweden
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/32—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB03867/67A GB1208014A (en) | 1967-03-23 | 1967-03-23 | Cephalosporins |
Publications (1)
Publication Number | Publication Date |
---|---|
SE364284B true SE364284B (zh) | 1974-02-18 |
Family
ID=10030837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE388168A SE364284B (zh) | 1967-03-23 | 1968-03-22 |
Country Status (7)
Country | Link |
---|---|
CH (1) | CH507984A (zh) |
DE (1) | DE1770031A1 (zh) |
DK (1) | DK124265B (zh) |
FR (2) | FR1556822A (zh) |
GB (1) | GB1208014A (zh) |
NL (1) | NL156702B (zh) |
SE (1) | SE364284B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1389194A (en) * | 1971-01-29 | 1975-04-03 | Glaxo Lab Ltd | Antibiotics |
IE36041B1 (en) * | 1971-01-29 | 1976-08-04 | Glaxo Lab Ltd | Improvements in or relating to antibiotics |
JPS5248996B1 (zh) * | 1971-01-29 | 1977-12-14 | Glaxo Lab Ltd | |
GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
GB1575803A (en) * | 1976-03-09 | 1980-10-01 | Fujisawa Pharmaceutical Co | 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof |
DE2818263A1 (de) * | 1978-04-26 | 1979-11-08 | Bayer Ag | Beta-lactamantibiotika |
IT1211080B (it) * | 1981-07-21 | 1989-09-29 | Craf Sud | Idrazonocefem derivati biologicamente attivi. |
GB8810393D0 (en) * | 1988-05-03 | 1988-06-08 | Glaxo Group Ltd | Chemical process |
CA2721944C (en) | 2008-04-24 | 2016-06-07 | F2G Ltd | Pyrrole antifungal agents |
CA2982660C (en) | 2014-11-21 | 2023-01-24 | F2G Limited | 2-(1,5-dimethyl-3-phenyl-1h-pyrrol-2-yl)-n-(4-(4-(5-fluoropyrimidin-2-yl)piperazine-1-yl)phenyl)-2-oxoacetamide and derivatives thereof for use as antifungal agents |
GB201609222D0 (en) | 2016-05-25 | 2016-07-06 | F2G Ltd | Pharmaceutical formulation |
US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
-
1967
- 1967-03-23 GB GB03867/67A patent/GB1208014A/en not_active Expired
-
1968
- 1968-03-20 CH CH411968A patent/CH507984A/de not_active IP Right Cessation
- 1968-03-20 FR FR1556822D patent/FR1556822A/fr not_active Expired
- 1968-03-20 FR FR144493A patent/FR7572M/fr not_active Expired
- 1968-03-22 SE SE388168A patent/SE364284B/xx unknown
- 1968-03-22 NL NL6804139A patent/NL156702B/xx unknown
- 1968-03-22 DE DE19681770031 patent/DE1770031A1/de not_active Ceased
- 1968-03-22 DK DK124068A patent/DK124265B/da unknown
Also Published As
Publication number | Publication date |
---|---|
GB1208014A (en) | 1970-10-07 |
NL6804139A (zh) | 1968-09-24 |
NL156702B (nl) | 1978-05-16 |
FR7572M (zh) | 1970-01-05 |
FR1556822A (zh) | 1969-02-07 |
DK124265B (da) | 1972-10-02 |
DE1770031A1 (de) | 1971-09-16 |
CH507984A (de) | 1971-05-31 |